Fluocinolone Acetonide Ear Drops Recalled Due to Failed Specification
Glenmark Pharmaceuticals is recalling Fluocinolone Acetonide Oil 0.01% ear drops due to failed excipient specifications. The affected lots nationwide do not meet required quality standards for isopropyl alcohol content.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall due to failed pharmaceutical excipient quality specifications. With no reported adverse events or illnesses, this represents a precautionary quality control issue rather than an identified serious health hazard.
Plain-English summary
Glenmark Pharmaceuticals Inc., USA, is recalling Fluocinolone Acetonide Oil 0.01% (Ear Drops) because the product failed excipient specifications. Specifically, the isopropyl alcohol content in the affected lots did not meet required quality standards.
The recall affects 38,496 bottles distributed nationwide. The affected lot numbers are 05220346 and 05220369 (expiring 1/31/2024), 05220582 (expiring 2/29/2024), and 05220861 (expiring 3/31/2024). The product is manufactured by Glenmark Pharmaceuticals Ltd. in India and distributed by Glenmark Pharmaceuticals Inc., USA, under NDC 68462-185-56.
Patients using affected medication should contact their healthcare provider. Healthcare providers and distributors should check their inventories against the lot numbers and contact their supplier for instructions regarding return or replacement of affected products.
The recalled product
- Product
- FLUOCINOLONE ACETONIDE (FLUOCINOLONE ACETONIDE)
- Brand
- FLUOCINOLONE ACETONIDE
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Category
- Drug — Prescription Drug
- Affected units
- 38,496
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot #: 05220346
- 05220369 Exp 1/31/ 2024
- 05220582
- Exp 2/29/2024
- 05220861 Exp 3/31/2024
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · FLUOCINOLONE ACETONIDE
- ModerateFluocinolone topical solution recalled after failing an impurity specification
FDA (Drugs) · 2026-01-21
- ModerateLupin Recalls Fluocinolone Acetonide Topical Solution Due to Impurities
FDA (Drugs) · 2019-01-30
- ModerateLupin Recalls Fluocinolone Acetonide Topical Solution Due to Impurity Failures
FDA (Drugs) · 2018-10-31
- HighLyne Laboratories Recalls Subpotent Fluocinolone Acetonide Topical Oil
FDA (Drugs) · 2018-05-02
- ModerateLyne Laboratories Recalls Subpotent Fluocinolone Acetonide Ear Drops
FDA (Drugs) · 2018-05-02
Same manufacturer · Glenmark Pharmaceuticals Inc., USA
See all →- ModerateAzelaic Acid Gel 15% Recalled Over Grainy, Gritty, or Sandy Texture
FDA (Drugs) · 2026-08-05
- ModerateAlyacen 7/7/7 birth control tablets failed total impurities specification
FDA (Drugs) · 2026-06-24
- ModerateOndansetron tablets recalled because blister packs are not fully sealed
FDA (Drugs) · 2026-01-07
- CriticalFrozen chopped methi recalled after testing positive for Salmonella
FDA (Drugs) · 2025-12-17
- ModerateBisoprolol and hydrochlorothiazide tablets recalled over traces of another drug
FDA (Drugs) · 2025-12-10
Same hazard · specification failure
See all →- ModerateZeiss Intrabeam Spherical Applicator failed manufacturing specifications
FDA (Devices) · 2026-07-08
- CriticalPericardial patches recalled because a lot may not meet tensile strength
FDA (Devices) · 2025-12-03
- CriticalSmaller pericardial patches recalled over a tensile strength specification failure
FDA (Devices) · 2025-12-03
- HighSkin cancer aid recalled because it may not meet specifications
FDA (Devices) · 2025-12-03
- Low